Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.


TSXV:MPH - Post by User

Bullboard Posts
Comment by amp7on Mar 08, 2008 10:59am
537 Views
Post# 14619268

RE: Glaring Question - amp7

RE: Glaring Question - amp7We don’t know the details on the trial, so it’s virtually impossible to put a realistic value on the pipeline or the company. Market is saying it’s worth less than zero. IMHO, guys like Hoie only invest big when they see themselves winning either way; if MC1 works I win big, if MC1 fails I still win, just not as big. We could see a friendly merger with Hoie’s company and a shift in strategy for selling MC1. Hoie may be looking for a way to sell his products on this side of the pond. For all we know, he may have sold out. All speculation at this time. What I do know is that for every seller, there has to be a buyer. I don’t see fund managers or retail investors buying the volumes we saw in the first three days. The question becomes, if Hoie was the buyer and has a plan, do retail investors benefit from it. I’m betting what we end up with is worth a good deal more than 8 cents a share but it’s anyone’s guess at this point.
Bullboard Posts